Our NAV-005 antagonist binds the immunosuppressive HIO-1 factor and blocks its ability to suppress mAb, TCE and ADC ...
News Medical on MSN
Antibody-producing plasma cells shape effectiveness of PD-1 immunotherapy
Scientists at the Icahn School of Medicine at Mount Sinai have identified an important immune response that helps explain why ...
On the criteria that matter to medicine—not later industrial power— Africa led . Medicine does not exist in isolation. It depends on cities, sanitation, governance, and trade. Africa’s medical ...
Scientists at the Icahn School of Medicine at Mount Sinai have identified an important immune response that helps explain why ...
Takeda (TSE:4502/NYSE:TAK) today announced the U.S. availability of GAMMAGARD LIQUID™ ERC [immune globulin infusion (human)] ...
New partner leadership to help deepen relationships with data, orchestration, and core platform providers embedded ...
ReAlta Life Sciences Inc. ("ReAlta" or the "Company"), a clinical-stage biopharmaceutical company focused on safely targeting neutrophils and central components of the complement system to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results